MetaCap

Who Owns Cue Biopharma Stock?

NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.15-0.35 (-7.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
33.90%
Institutional holders
66
  • Institutions 33.9%
  • Insiders 16.6%
  • Public and other 49.5%

Who owns Cue Biopharma stock?

Institutional investors own about 33.9% of Cue Biopharma's shares, spread across 66 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 16.57% of CUE.

The largest institutional holders are Bleichroeder LP (5.04%), Vanguard Capital Management LLC (4.27%) and Driehaus Capital Management, LLC (4.02%). Together, the top 10 institutions control 26.5% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their CUE positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CUE

Cue Biopharma top institutional holders
InstitutionShares% HeldChange
Bleichroeder LP366.15K5.04%-1.2%
Vanguard Capital Management LLC309.95K4.27%+91.7%
Driehaus Capital Management, LLC292.14K4.02%+100.0%
Vivo Capital, LLC280.06K3.86%+100.0%
Morgan Stanley203.96K2.81%+30160.7%
UBS Group AG111.50K1.53%+317.6%
Ikarian Capital, LLC104.36K1.44%+100.0%
Nantahala Capital Management, LLC96.05K1.32%+100.0%
Tetragon Partners GP Ltd.93.82K1.29%+100.0%
Geode Capital Management, LLC68.91K0.95%+44.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CUE

Cue Biopharma top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund111.87K1.54%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund47.09K0.65%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund31.09K0.43%
Fidelity Concord Street Trust-Fidelity Total Market Index Fund11.90K0.16%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund10.47K0.14%
iShares Trust-iShares Micro-Cap ETF8.70K0.12%
Dimensional ETF Trust-Dimensional U.S. Small Cap ETF1.81K0.02%
VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund1.72K0.02%
VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd.1.02K0.01%
EQ Advisors Trust-1290 VT Micro Cap Portfolio7470.01%

Frequently asked questions

Who is the largest shareholder of Cue Biopharma?

Bleichroeder LP is the largest institutional shareholder of CUE, owning 5.04% of shares outstanding (366.15K shares) as of its latest 13F filing.

What percentage of Cue Biopharma is owned by institutions?

Institutions own about 33.9% of CUE shares and 40.6% of the public float.

How much of Cue Biopharma do insiders own?

Insiders, such as officers and directors, own about 16.57% of CUE shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related